{"id":"W4306757577","doi":"10.1016/j.kint.2022.09.017","title":"Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy","year":2022,"lang":"en","type":"article","venue":"Kidney International","topic":"Renal Diseases and Glomerulopathies","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Placebo; Medicine; Renal function; Clinical endpoint; Urology; Budesonide; Adverse effect; Internal medicine; Randomized controlled trial; Clinical trial; Nephropathy; Kidney disease; Gastroenterology; Corticosteroid; Pathology; Endocrinology; Diabetes mellitus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004967232,0.00236663,0.003676743,0.0004795923,0.0006601218,0.001068259,0.0008604578,0.00329358,0.01000274],"category_scores_gemma":[0.003461722,0.0007834992,0.002262426,0.000431454,0.000905098,0.0009879383,0.0003451576,0.002582401,0.001281066],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006075227,"about_ca_system_score_gemma":0.001349414,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008013311,"about_ca_topic_score_gemma":0.001542425,"domain_scores_codex":[0.9984067,0.0008716778,0.0001329016,0.0002567949,0.0001872291,0.0001446292],"domain_scores_gemma":[0.9977139,0.0007468117,0.0005515921,0.0002258565,0.0002763599,0.0004853874],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9553865,0.00978067,0.0009815134,0.001529541,0.002263565,0.00008128752,0.00004662562,0.0003549332,0.009007995,0.0001498139,0.003285292,0.01713229],"study_design_scores_gemma":[0.9515428,0.04046845,0.004013308,0.00005880521,0.001140251,0.00004358898,0.00000920903,0.0001082484,0.0009114107,0.0001289097,0.001550323,0.00002468371],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.889568,0.02369644,0.005068839,0.00293975,0.001466703,0.03781382,0.02760041,0.0004599349,0.01138628],"genre_scores_gemma":[0.9199273,0.01230847,0.00832595,0.005037729,0.001078817,0.02362847,0.02187145,0.0001129432,0.007708941],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01000274,"threshold_uncertainty_score":0.03346246,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0392503578415708,"score_gpt":0.3058367754631991,"score_spread":0.2665864176216283,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}